Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative
PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that clinical technology companies CRF Health and Clinical Ink have joined its Perceptive Partner Program. Through the program, technology, consulting, reseller and training companies, as well as contract research organizations (CROs), can enhance and broaden their services to biopharmaceutical customers by leveraging the Perceptive MyTrials eClinical platform along with clinical and technical support services.
Perceptive MyTrials is one of the industry’s leading suites of applications for managing clinical trials. Its flexible, open architecture allows partners to integrate targeted, specialized solutions within the platform. This gives their sponsor customers efficient access to clinical data and applications from a single source, allowing them to more efficiently and effectively manage critical trial activities.
“To better ensure the safety and timeliness of their trials, our customers are increasingly seeking efficient approaches to patient screening, enrollment and randomization,” said Rachael Wyllie, CEO of CRF Health. “As a Perceptive partner, we can address these needs by integrating our electronic Clinical Outcome Assessments [eCOA] offering with Perceptive MyTrials randomization and electronic data capture technologies.”
Ed Seguine, CEO of Clinical Ink, said, “Integrating solutions from Perceptive MyTrials into our SureSource clinical platform will provide sponsors with proven trial management solutions in a user-friendly tablet PC system. This presents a powerful combination of functionality and mobility.”
As study designs become increasingly complex, sponsors are relying on eClinical technologies to manage protocols and evolving regulatory requirements. Developed in 2013 and consisting of an ecosystem of technology and CRO partners, the Perceptive Partner Program offers support services and training that enable service providers to integrate their offerings with individual or collective Perceptive MyTrials applications including:
* DataLabs Electronic Data Capture (EDC)
* ClinPhone Randomization and Trial Supply Management (RTSM)
* IMPACT Clinical Trial Management System (CTMS)
* Electronic Patient Reported Outcomes (ePRO)
* Medical Imaging
* Perceptive MyTrials Data-Driven Monitoring
* LIQUENT Insight Regulatory Information Management
“Sponsors continue to seek fully integrated, best-of-breed technology solutions and clinical outsourcing services that can be efficiently managed,” said Graham Bunn, Vice President, Perceptive Partner Program. “Adding CRF Health and Clinical Ink to our partner program further reinforces its value proposition as the industry’s premier partnership initiative for simplifying drug development.”
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.